Delivery Order SPE2DR25D2006-SPE2DR26F57EL
- Not listed
- The Defense Logistics Agency awarded a $2,369.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of December 24, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,184.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This is a competitive award with no set-aside designation and an ultimate completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,184.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of November 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office in...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product, with an ultimate completion date of October 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for XDEMVY 0.25% drop in 10ML format, with performance completing by August 4, 2025. This competitively awarded, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under a larger federal contract vehicle. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,447.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml format. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,670.77 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop in 10ml format, with an ultimate completion date of October 21, 2025. This competitive award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product for federal medical procurement. This firm fixed-price delivery order, issued on December 30, 2025, is scheduled for completion by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical products. This firm fixed-price, competitively awarded contract was issued on December 1, 2025, with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57ELDelivery Order
The Defense Logistics Agency awarded a $2,369.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ML format on January 7, 2026, with an ultimate completion date of January 29, 2026. This non-competitive delivery order is being performed in Conshohocken, Pennsylvania, the location of the contractor's corporate office. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order exemplifies the operational structure of the DLA's pharmaceutical supply chain, whereby task orders for specific medications and medical commodities are issued against master contract vehicles to fulfill government healthcare requirements. AmerisourceBergen, as a major pharmaceutical distributor, maintains critical relationships with federal agencies including the Defense Health Agency and operates within the competitive landscape of the DLA's proposed Pharmaceutical Prime Vendor Global Program Generation V initiative. The modest order value reflects the transaction-based nature of individual delivery orders supporting military treatment facilities and veteran healthcare programs across the federal medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/6/26 |